©The Author(s) 2024.
World J Gastrointest Endosc. Apr 16, 2024; 16(4): 178-186
Published online Apr 16, 2024. doi: 10.4253/wjge.v16.i4.178
Published online Apr 16, 2024. doi: 10.4253/wjge.v16.i4.178
Table 1 Current commercially-available endoscopic bariatric therapies within the United States
| Endoscopic bariatric therapies |
| Food and Drug Administration authorized |
| ESG with Apollo ESGTM |
| Transoral outlet reduction with Apollo reviseTM |
| Orbera® intragastric balloon |
| Spatz3 intragastric balloon |
| Off-label or experimental procedures |
| Endoscopic gastroplasty with Endomina®* |
| Primary obesity surgery endoluminal 2.0 procedure with incisionless operating platform®* |
| Endoscopic revision of vertical sleeve gastrectomy (with Apollo OverStitchTM, Endomina®, or the incisionless operating platform®) |
- Citation: Maselli DB, Donnangelo LL, Coan B, McGowan CE. How to establish an endoscopic bariatric practice. World J Gastrointest Endosc 2024; 16(4): 178-186
- URL: https://www.wjgnet.com/1948-5190/full/v16/i4/178.htm
- DOI: https://dx.doi.org/10.4253/wjge.v16.i4.178